Skip to main content
SpringerLink
Log in

Co-administration of bivalent mRNA COVID-19 and influenza vaccines: no new or unexpected safety concerns

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Moro PL, et al. Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS). Drug Safety : 27 Feb 2024. Available from: URL: https://doi.org/10.1007/s40264-024-01406-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Co-administration of bivalent mRNA COVID-19 and influenza vaccines: no new or unexpected safety concerns. Reactions Weekly 1998, 10 (2024). https://doi.org/10.1007/s40278-024-53854-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53854-9

Search

Navigation